Current funding opportunities relevant to researchers in the ABA community can be found here. Be sure to check back for updates. If you know of an opportunity that should be listed here, please contact the Central Office.

Additional Resources

Webinars: The Congressionally Directed Medical Research Programs provides webinar series on types of funding opportunities offered and strategies to applying.

FY20 Military Burn Research Program (MBRP)

Clinical Translational Research Award

Announced: March 16, 2020
Pre-Proposal Due: May 15, 2020
Amount: $1.5 total costs

DTRA (DOD)

Fundamental Research to Counter Weapons of Mass Destruction

Announced: December 16, 2019
Due: September 30, 2024
Amount: Not Specified

DOD USAMRMC (W81XWH18SBAA1)

FY18-FY22 Broad Agency Announcement for Extramural Medical Research

Due: September 30, 2020
Amount: Not Specified

PAR-18-597

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trail Not Allowed)

Announced: January 29, 2018
Due: November 3, 2020
Amount: Not Specified

PA-19-056

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Announced: November 5, 2018
Due: January 5, 2022
Amount: Not Specified

PA-19-065

Medical Simulators for Practicing Patient Care Providers Skill Acquisition, Outcomes Assessment and Technology Development (R01 Clinical Trial Not Allowed)

The purpose of the Funding Opportunity Announcement (FOA) is to promote the assessment and further development of simulation technologies intended to improve patient safety and healthcare outcomes provided by practicing patient care providers and experienced (not trainee) physicians. The FOA seeks applications directed toward three areas of research: 1) Skill Acquisition: to evaluate strategies and protocols for simulation-based methods for skill acquisition and maintenance by experienced clinicians; 2) Outcomes Assessment: to assess the relationship of simulation-based assessments of skills demonstrated by experienced clinicians with the quality of clinical care delivered by those clinicians, and to identify strategies to increase the quality of simulation-based assessments of skills; and 3) Technology Development: to develop virtual coaches by incorporating intelligent technologies into existing simulators to provide adaptive, cognitive assistance to coach experienced practitioners in retaining, retraining and improving performance levels in the context of the user environment (and physiological system as appropriate).

Announced: November 13, 2018
Due: January 7, 2022
Amount: Not Specified

PA-19-055

Research Project Grant (Parent R01 Clinical Trial Required)

The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. Applicants should note that some ICs (see Related Notices) only accept applications proposing mechanistic studies that meet NIH’s definition of a clinical trial through this funding opportunity announcement.

Announced: November 5, 2018
Due: February 1, 2022
Amount: Not Specified

PAR-18-952

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare disease research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.

Announced: October 4, 2018
Due: October 1, 2021
Amount: $50,000